Immunotherapeutic hydrogel for co-delivery of STAT3 siRNA liposomes and lidocaine hydrochloride for postoperative comprehensive management of NSCLC in a single application

• Main Authors: Xianglei Fu (Author), Yanbin Shi (Author), Zili Gu (Author), Hengchang Zang (Author), Lian Li (Author), Qingjie Wang (Author), Yongjun Wang (Author), Xiaogang Zhao (Author), Hang Wu (Author), Shengnan Qiu (Author), Yankun Zhang (Author), Jiamin Zhou (Author), Xiangqin Chen (Author), Hua Shen (Author), Guimei Lin (Author)
• Format: Book
• Published: Elsevier, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Despite standard treatment for non-small cell lung cancer (NSCLC) being surgical resection, cancer recurrence and complications, such as induction of malignant pleural effusion (MPE) and significant postoperative pain, usually result in treatment failure. In this study, an alginate-based hybrid hydr...